AstraZeneca PLC 13D/13G Filings for Conduit Pharmaceuticals Inc. (CDT)

AstraZeneca PLC 13D and 13G filings for Conduit Pharmaceuticals Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-10-11
06:01 am
Purchase
2024-08-0713GConduit Pharmaceuticals Inc.
CDT
AstraZeneca PLC95,045
9.900%
95,045increase
(New Position)
Filing